Review of bacteriology and preclinical studies and clinical pharmacology of gentamicin sulfate.
D000818:Animals; D002415:Cats; D002986:Clinical Trials as Topic; D003051:Cochlea / Q000187:drug effects; D004754:Enterobacter / Q000187:drug effects; D004755:Enterobacteriaceae / Q000187:drug effects*; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000097:blood / Q000494:pharmacology* / Q000633:toxicity; D006801:Humans; D007673:Kidney Cortex Necrosis / Q000139:chemically induced; D007684:Kidney Tubules / Q000187:drug effects; D007709:Klebsiella / Q000187:drug effects; D007759:Labyrinth Diseases / Q000139:chemically induced; D051379:Mice; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D051381:Rats; D012475:Salmonella / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D013431:Sulfates / Q000097:blood / Q000494:pharmacology / Q000633:toxicity; D014722:Vestibule, Labyrinth / Q000187:drug effects
D005839:Gentamicins; D013431:Sulfates